prikaz prve stranice dokumenta Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients
Medical Hypotheses, 82 (2014), 2; 205-208. https://doi.org/10.1016/j.mehy.2013.11.039
Mikolašević, Ivana; Rački, Sanjin; Zaputović, Luka.; Lukenda, V.; Milić, Sandra; Orlić, Lidija

Citirajte ovaj rad

Mikolašević, I., Rački, S., Zaputović, L., Lukenda, V., Milić, S. i Orlić, L. (2014). Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients. Medical Hypotheses, 82. (2), 205-208. doi: 10.1016/j.mehy.2013.11.039

Mikolašević, Ivana, et al. "Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients." Medical Hypotheses, vol. 82, br. 2, 2014, str. 205-208. https://doi.org/10.1016/j.mehy.2013.11.039

Mikolašević, Ivana, Sanjin Rački, Luka. Zaputović, V. Lukenda, Sandra Milić i Lidija Orlić. "Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients." Medical Hypotheses 82, br. 2 (2014): 205-208. https://doi.org/10.1016/j.mehy.2013.11.039

Mikolašević, I., et al. (2014) 'Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients', Medical Hypotheses, 82(2), str. 205-208. doi: 10.1016/j.mehy.2013.11.039

Mikolašević I, Rački S, Zaputović L, Lukenda V, Milić S, Orlić L. Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients. Medical Hypotheses [Internet]. 02.2014. [pristupljeno 16.12.2024.];82(2):205-208. doi: 10.1016/j.mehy.2013.11.039

I. Mikolašević, S. Rački, L. Zaputović, V. Lukenda, S. Milić i L. Orlić, "Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients", Medical Hypotheses, vol. 82, br. 2, str. 205-208, Veljača 2014. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:432619. [Citirano: 16.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:432619
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Nonalcoholic fatty liver disease (NAFLD): A new risk factor for adverse cardiovascular events in dialysis patients
AutorIvana Mikolašević
AutorSanjin Rački
AutorLuka. Zaputović
AutorV. Lukenda
AutorSandra Milić
AutorLidija Orlić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. Today it is believed that NAFLD is a hepatic manifestation of metabolic syndrome, and thus it is closely related to the cardiovascular morbidity and mortality. Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in patients with end-stage-renal disease (ESRD). NAFLD and ESRD share some important cardiometabolic risk factors and possible common pathophyisiological mechanisms, and are linked to an increased risk of incident CVD events. We hypothesize that the coexistence of these two conditions could lead to much faster progress of the aterogenic process. Furthermore, patients with ESRD who suffer from NAFLD have a much higher risk for the development of adverse CVD events. Given the high prevalence of NAFLD, and its tight association with other manifestations of the metabolic syndrome and thus cardiovascular complications, it is important to recognize and aggressively treat this condition in ESRD patients. To evaluate this hypothesis, we propose the use of non-invasive methods such as transient elastography (TE) (Fibroscan-CAP) for the detection and quantification of liver steatosis and fibrosis, as well as an abdominal ultrasound for detecting liver steatosis. We focus on their correlation with carotid intima-media thickness (IMT) and plaque as surrogate measures of increased cardiovascular risk in HD patients in order to investigate the association of NAFLD and increase risk of adverse CVD events. This evaluation will prove useful in assessing the risk in HD patients with NAFLD for increase CVD mortality.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaMedical Hypotheses
Brojčani podacivol. 82, br. 2, str. 205-208
p-ISSN0306-9877
DOIhttps://doi.org/10.1016/j.mehy.2013.11.039
URN:NBNurn:nbn:hr:184:432619
Datum objave publikacije2014-02
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S0306987713005689
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-09-20 09:46:23